Skip to nav Skip to content

Research & Funding for Other Faculty

Facebook Twitter LinkedIn Email

IDSA Foundation: IDea Incubator (Deadline: August 2022) 

A pitch-style  competition,  IDea Incubator encourages innovators and early-stage ventures with original inventions, products and ideas  for improving with the potential to improve  ID  care to share their ideas with the ID community and judges in the business, medicine and technology industries. 

IDSA Foundation: HIV Clinical Fellowship Program (Deadline: November 8, 2021) 

The program supports non-infectious diseases physicians with gaining HIV clinical experience working with medically underserved patient populations. 

IDSA Foundation: Microbial Pathogenesis In Alzheimer’s Disease Grant (Deadline: August 31, 2021) 

These grants support research that suggest evidence of an infectious agent or microbial community is correlated to Alzheimer’s disease and promotes novel research in the field of microbial triggers for Alzheimer’s disease. 

Centers for Disease Control and Prevention Training Programs(Deadline: Ongoing) 
Research and public health training programs and fellowships. CDC has many diverse fellowship, internship, training, and volunteer opportunities for students and professionals. 

Fulbright Programs for US Scholars (Deadline: September 15, 2021) 
Fulbright programs annually offer U.S. faculty, administrators and professionals grants to lecture, conduct research in a wide variety of academic and professional fields, or to participate in seminars. 

Fulbright Programs for Non-US Scholars(Deadline: Ongoing) 
Annual programs support research and teaching, and outreach lecturing of visiting scholars to the U.S., alongside internationalization efforts of U.S. campuses. 

US Department of Veterans Affairs Career Development Program 
Provides mentoring for junior researchers, clinicians and non-clinicians, so they can learn from renowned, experienced VA researchers. Awards are provided in biomedical laboratory, clinical science, health services, and rehabilitation research. 

Biomedical Laboratory R&D (Deadline: May 1, November 1) 

Clinical Science R&D (Deadline: May 1, November 1) 

Health Services R&D (Deadline: April 15, October 15) 

Rehabilitation R&D (Deadline: May 1, November 1) 

Burroughs Welcome Fund Resident Faculty Scholar (Deadline: September 9) 

The Resident Faculty Scholar Grant Program will support a faculty member, or small groups of faculty members, at institutions in the United States or Canada, to utilize BWF Headquarters as a site for mini-sabbaticals/project incubation allowing the dedicated protected time to initiate or accelerate their work when aligned with BWF priorities and goals. 

March of Dimes Research Grants (Deadline: September 10, 2021) 

March of Dimes is actively seeking applications for research grant funding that involve translational and actionable science that will lead directly to interventions or preventions. 

NIAID Fellowship Grants 
NIH awards National Research Service Award (NRSA) individual fellowship grants to provide research experience to students and scientists at various stages of their careers. 

F30, F31 and F32 (non-AIDS) (Deadline: April 8, August 8, and December 8) 

AIDS and AIDS-related fellowship applications follow standard AIDS due dates (Deadline: May 7, September 7, and January 7) 

NIAID Antibacterial Resistance Leadership Group (ARLG) (Deadline: December 1) 
Seeking proposals for clinical studies to address antibacterial resistance, including infections caused by Gram-negative and Gram-positive bacteria, antimicrobial stewardship and infection prevention, and diagnostics. 
Application/Review Process   

NIH Common Fund High Risk-High Reward Programs  (Deadline: Ongoing)

The High-Risk, High-Reward Research program supports exceptionally creative scientists pursuing highly innovative research with the potential for broad impact in biomedical, behavioral, or social sciences within the NIH mission. Preliminary data are not required. The program's four constituent NIH Director's awards provide a diverse set of funding opportunities. See the individual awards below.  

NIH Director's Pioneer Award Program (Deadline: September 15, 2021) 

The award supports scientists with outstanding records of creativity pursuing new research directions to develop pioneering approaches to major challenges in biomedical, social science, and behavioral research. 

NIH Director's Transformative Research Award Program(Deadline: September 1, 2021) 

The award supports individuals or teams proposing transformative projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms and may require very large budgets.

NIH Fogarty International Center Funding Opportunities     (Deadline: Ongoing) 

Fogarty's programs provide funding to perform research and to train researchers in a variety of global health areas. See program pages for status, eligibility, funding announcements and deadlines. 

Pediatric Infectious Diseases Society Fellowships and Research Awards (Deadline: Ongoing) 
Funding opportunities offered to members of the Pediatric Infectious Diseases Society to stimulate scholarly basic, translational, and clinical research in areas pertinent to Pediatric Infectious Diseases including innovative research to improve or develop new vaccines and immunotherapeutics for children. 

Thrasher Research Fund: E.W. “Al”  Thrasher Awards (Deadline: Ongoing) 

Offering awards in pediatric medical research. The E.W. "Al" Thrasher Awards seeks to improve children's health through medical research, with an emphasis on projects that have the potential to translate into clinically meaningful results within a few years. The Fund awards grants two times per year, with no fixed number of awards given in each funding cycle or in each year. 

Howard Hughes Medical Institute: Investigator Program (Deadline: September 2, 2021) 

HHMI employs and supports more than 250 Investigators, who are based at over 60 universities, colleges, and other research institutions across the US. In addition to their research programs, HHMI Investigators participate in educational activities and hold leadership roles at these host institutions. (Deadline: Ongoing) 
Search and apply for competitive grant opportunities from all federal grant-making agencies  

National Biosafety & Biocontainment Training Program (Deadline: August 2022) 

NBBTP is a 2 year program to train fellows to work in high containment research environments by acquiring knowledge and skills necessary to meet the scientific, regulatory, biocontainment, biosafety, engineering, communications, management, and public relations challenges associated with the conduct of research in these facilities.     

Dissemination and Implementation Research in Health (R01, Clinical Trial Optional) (Deadline: Ongoing) 
The purpose of this Funding Opportunity Announcement (FOA) is to support innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. 

Dissemination and Implementation Research in Health (R21, Clinical Trial Optional) (Deadline: Ongoing)  
The purpose of this Funding Opportunity Announcement (FOA) is to support innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. 

Gilead Medical Affairs Investigator Sponsored Research (Deadline: August) 
Gilead provides ISR grants primarily in our therapeutic areas of expertise and based on the scientific merit of the proposal. The research must be intended to contribute knowledge to the medical community, and will be reviewed by a Gilead cross functional committee. 

PrEP for HIV Prevention among Substance Using Populations (R01-Clinical Trial Option) (November 12, 2021) 
The National Institute of Drug Abuse (NIDA) is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. 

Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes  (Deadline: October 5, 2021)

This Notice of Special Interest (NOSI) aims to stimulate multidisciplinary research collaborations that utilize cutting-edge technologies to apply progress made in SCGE to transplantation research. Research funded by this NOSI may utilize various models, including human tissues or organs excluded from clinical use and/or rodent, porcine, or nonhuman primate models.

American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) (Deadline: December 9, 2021) 

The NIH will support multidisciplinary epidemiological research to better understand HIV transmission, prevention, and early cascade points in American women infected with HIV.  

PAR-20-213 - National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed) (Deadline: Ongoing)

This funding opportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to integrated dual-degree training leading to the award of both clinical degrees, e.g., M.D., D.O., D.V.M., D.D.S., Pharm.D., and research doctorate degrees (Ph.D.).

Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide (Deadline: May 8, 2024) 

The NIH issued a NOSI to communicate special interest in epidemiology investigations to quantify the impact of the coronavirus disease 2019 (COVID-19) pandemic on Human Immunodeficiency Virus (HIV) prevention, incidence, transmission, and outcomes. 

Emergency Awards: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) (Deadline: October 21, 2021) 

The program supports comprehensive multidisciplinary research focused on innovative antiviral drug development targeting coronaviruses (CoVs), emphasizing SARS-CoV-2, and one or more select RNA viruses with pandemic potential. 

Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) (Deadline: December 14, 2021)

The purpose of the Funding Opportunity Announcement (FOA) is to support research that employs systems biology approaches to human pathogens.  The approach will generate and integrate large datasets into models that guide in vitro, in vivo and clinical studies, with the goals of predicting disease severity, predicting responses to vaccines and therapeutics, and identifying candidate targets for interventions.

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) (Deadline: May 21, 2021) 

SuRE is a research capacity building program designed to develop and sustain research excellence in U.S. higher education institutions that receive limited NIH research support and serve students from groups underrepresented in biomedical research NOT-OD-20-031 with an emphasis on providing students with research opportunities and enriching the research environment at the applicant institutions. 

Burroughs Welcome Fund: Career Awards at the Scientific Interface (Deadline: September 1, 2021) 

BWF's Career Awards at the Scientific Interface (CASI) provide $500,000 over five years to bridge advanced postdoctoral training and the first three years of faculty service. These awards are open to U.S. and Canadian citizens, permanent residents, and temporary residents. 

Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) (Deadline: May 25, 2022 and September 25, 2022)

The purpose of this Funding Opportunity Announcement (FOA) is to provide continued support for the National Swine Resource and Research Center (NSRRC). The NSRRC serves as a central resource for the creation of genetically modified swine in response to the needs of the community and the cryopreservation of genetic stocks, procurement, and distribution of those swine, reagents, and their biological materials; and as a source of information and training related to the use of these animals in biomedical research as models of human health and disease.

Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery (Deadline: Ongoing)

The purpose of this Notice of Special Interest (NOSI) is to inform potential applicants about an area of special interest to NIAID on early phase translational research that will generate new malaria vaccine candidates with desirable features suitable for further downstream development and clinical evaluation. This NOSI encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially Plasmodium falciparum and Plasmodium vivax.

Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship (Deadline: April 07, 2022)

The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing awards of scientists who are outstanding mentors and who have demonstrated compelling commitments and contributions to enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Excellent mentorship and superior training are critical to the development of exceptional future scientists. This administrative supplement recognizes the crucial role great mentors play in the development of future leaders in the scientific research enterprise.

Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed) (Deadline: June 8, 2022)

This Funding Opportunity Announcement (FOA) will support discovery and validation research for biomarkers and biomarker signatures that can identify children under 5 years of age with Tuberculosis (TB) infection and predict those more likely to progress to active TB disease, allowing targeted treatment to those at risk of progression.

Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection (Deadline: Ongoing)

This NOSI is intended to support projects that will employ existing and new clinical trial cohorts/observational cohorts to screen for co-infection, phenotype and collect biospecimens to answer some of these questions and to encourage investigator-initiated applications for basic, translational and human subject research (not clinical trials) in this space.

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) (Deadline: September 8, 2022)

This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.

Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine (Deadline: Ongoing)

The purpose of this Notice of Special Interest (NOSI) is to support research that contributes to the areas of interest outlined in “A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.” The proposed research should have clear relevance to the research objectives defined in the strategic plan, which encompasses three major research areas: improve understanding of transmission, natural history and pathogenesis of influenza virus infection, characterize influenza immunity and correlates of immune protection, and support rational design of universal influenza vaccines.



This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.